109 related articles for article (PubMed ID: 25961771)
1. Cutaneous macrophage infiltration in acute GvHD.
Terakura S; Martin PJ; Shulman HM; Storer BE
Bone Marrow Transplant; 2015 Aug; 50(8):1135-7. PubMed ID: 25961771
[No Abstract] [Full Text] [Related]
2. Expression of CD64 (FcγRI) in skin of patients with acute GVHD.
van Royen-Kerkhof A; Walraven V; Sanders EA; de Weger R; van Wichen DF; de Koning E; Thepen T; van de Winkel JG; Leusen JH
Bone Marrow Transplant; 2011 Dec; 46(12):1566-9. PubMed ID: 21243031
[TBL] [Abstract][Full Text] [Related]
3. LN-3: a diagnostic adjunct in cutaneous graft-versus-host disease.
Synovec MS; Braddock SW; Jones J; Linder J
Mod Pathol; 1990 Nov; 3(6):643-7. PubMed ID: 1702211
[TBL] [Abstract][Full Text] [Related]
4. Role of Toll-like receptor 4 signaling in cutaneous chronic graft-versus-host disease.
Weng J; Lai P; Geng S; Luo C; Wu S; Ling W; Deng C; Huang X; Lu Z; Du X
Clin Transplant; 2015 Jun; 29(6):547-54. PubMed ID: 25845646
[TBL] [Abstract][Full Text] [Related]
5. Keratinocyte-derived amyloidosis as a manifestation of chronic graft-versus-host disease.
Haemel A; Fox L; McCalmont TH
J Cutan Pathol; 2013 Mar; 40(3):291-4. PubMed ID: 23899263
[No Abstract] [Full Text] [Related]
6. Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis.
Firoz BF; Lee SJ; Nghiem P; Qureshi AA
Arch Dermatol; 2006 Feb; 142(2):175-82. PubMed ID: 16490845
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methods.
Lehman JS; Hashmi SK; Lazarus HM; El-Azhary RA; Gibson LE; Hogan WJ; Litzow MR; Patnaik MS; Buadi F; Lacy MQ; Dasari S; Vanderboom P; Meves A
J Cutan Pathol; 2017 Dec; 44(12):1087-1091. PubMed ID: 28906023
[No Abstract] [Full Text] [Related]
8. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
[TBL] [Abstract][Full Text] [Related]
9. Proliferative activity of CD8(+) T cells as an important clue to analyze T cell-mediated inflammatory dermatoses.
Deguchi M; Ohtani H; Sato E; Naito Y; Nagura H; Aiba S; Tagami H
Arch Dermatol Res; 2001 Sep; 293(9):442-7. PubMed ID: 11758786
[TBL] [Abstract][Full Text] [Related]
10. Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease.
Hillen U; Häusermann P; Massi D; Janin A; Wolff D; Lawitschka A; Greinix H; Meyer R; Ziemer M
J Eur Acad Dermatol Venereol; 2015 May; 29(5):948-54. PubMed ID: 25265987
[TBL] [Abstract][Full Text] [Related]
11. Expression of CCR5 in graft-versus-host disease (GVHD) of the skin: immunohistochemical staining of 38 cases.
Morita NI; Matsumura Y; Morita K; Miyachi Y
J Dermatol; 2007 Apr; 34(4):254-7. PubMed ID: 17352723
[TBL] [Abstract][Full Text] [Related]
12. Extra-domain-A fibronectin: a new marker of fibrosis in cutaneous graft-versus-host disease.
van der Straaten HM; Canninga-van Dijk MR; Verdonck LF; Castigliego D; Borst HP; Aten J; Fijnheer R
J Invest Dermatol; 2004 Dec; 123(6):1057-62. PubMed ID: 15610514
[TBL] [Abstract][Full Text] [Related]
13. Endothelial-cell injury in cutaneous acute graft-versus-host disease.
Dumler JS; Beschorner WE; Farmer ER; Di Gennaro KA; Saral R; Santos GW
Am J Pathol; 1989 Dec; 135(6):1097-103. PubMed ID: 2596572
[TBL] [Abstract][Full Text] [Related]
14. Pathology findings in patients with cutaneous T-cell lymphomas treated with allogeneic haematopoietic stem cell transplantation.
Menter T; Medani H; Olavarria E; Kanfer E; Naresh KN
Br J Haematol; 2018 Mar; 180(6):904-908. PubMed ID: 27984647
[No Abstract] [Full Text] [Related]
15. Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease.
Deguchi M; Aiba S; Ohtani H; Nagura H; Tagami H
Arch Dermatol Res; 2002 Oct; 294(7):297-302. PubMed ID: 12373334
[TBL] [Abstract][Full Text] [Related]
16. Acute follicular graft-vs-host reaction. A distinct clinicopathologic presentation.
Friedman KJ; LeBoit PE; Farmer ER
Arch Dermatol; 1988 May; 124(5):688-91. PubMed ID: 3284466
[TBL] [Abstract][Full Text] [Related]
17. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
18. Acute gut GVHD in children: does skin involvement matter?
Gassas A; Sung L; Dupuis A; Schechter T; Egeler M; Ali M
Bone Marrow Transplant; 2013 Aug; 48(8):1129-32. PubMed ID: 23474802
[TBL] [Abstract][Full Text] [Related]
19. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
Olson KA; West K; McCarthy PL
Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
[TBL] [Abstract][Full Text] [Related]
20. Acute cutaneous graft-vs.-host disease compared to drug hypersensitivity reaction with vacuolar interface changes: a blinded study of microscopic and immunohistochemical features.
Lehman JS; Gibson LE; el-Azhary RA; Chavan RN; Hashmi SK; Lohse CM; Flotte TJ
J Cutan Pathol; 2015 Jan; 42(1):39-45. PubMed ID: 25393781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
